OS Therapies Incorporated
OSTX
$2.50
$0.177.30%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.02% | -29.61% | -4.03% | -84.60% | -6.75% |
| Total Depreciation and Amortization | 15,971.43% | -50.00% | -- | -100.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | -68.89% | -- |
| Total Other Non-Cash Items | -16.41% | 143.04% | -- | -- | -200.00% |
| Change in Net Operating Assets | 584.70% | -195.50% | 136.96% | -608.03% | -29.81% |
| Cash from Operations | 31.42% | -44.95% | 29.85% | -284.11% | -37.32% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -68.66% | -- | -- | -- | -- |
| Cash from Investing | -68.66% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -100.00% | 5.76% |
| Total Debt Repaid | -- | -- | 100.00% | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -99.94% | -82.60% | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 814.11% | 83.72% |
| Cash from Financing | 135.90% | -82.60% | 17.52% | 487.74% | 24.59% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 93.40% | -169.72% | 108.45% | 33,367.92% | -108.66% |